ENG rs1060501419: Understanding This Genetic Variant
The variant rs1060501419 is a specific change located within the ENG gene region. It has been identified in genomic studies, though its functional impact and clinical significance remain subjects of ongoing research.
What each genotype means
Typical endoglin gene profile
This genotype represents the common, expected sequence for the ENG gene at this specific location. Individuals with this genotype do not carry the pathogenic alteration (c.904G>T; p.Glu302Ter) associated with this specific ENG record.
This is the most common genotype observed in the general population.
Pathogenic HHT-associated variant
This genotype indicates you carry one copy of the ENG p.Glu302Ter (or c.904G>T) variant. This variant is considered pathogenic and is associated with Hereditary Hemorrhagic Telangiectasia (HHT), a condition that affects blood vessel structure. Please discuss this result with a medical geneticist or your primary healthcare provider to understand its implications for your health.
This genotype is extremely rare and is not found at significant frequencies in general population databases.
Pathogenic HHT-associated variant
This genotype indicates you carry two copies of the ENG p.Glu302Ter (or c.904G>T) variant. This variant is classified as pathogenic and is linked to the development of Hereditary Hemorrhagic Telangiectasia (HHT). It is essential to discuss this result with a clinical geneticist or your physician for appropriate diagnostic or management steps.
This genotype is exceedingly rare and has not been established as a common occurrence in any known population.
What is rs1060501419?
The identifier rs1060501419 refers to a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This specific variant is located within the genomic region of the ENG gene. In the context of human genetics, SNPs are the most common type of genetic variation, often serving as markers that researchers use to study the architecture of the genome. While many SNPs have no observable effect on health, others are studied for their potential associations with specific traits or conditions. Because rs1060501419 is cataloged in genomic databases, it is frequently included in large-scale association studies that aim to map the relationship between genetic diversity and human biology. It is important to note that being listed in a database does not imply that a variant causes a disease; rather, it indicates that the site has been documented as a point of variation in human populations.
The Role of the ENG Gene
The ENG gene provides the instructions for creating a protein known as endoglin. This protein is primarily found on the surface of cells, particularly those that line the interior of developing blood vessels. Endoglin plays a critical role in the cardiovascular system by forming complexes with various growth factors and other proteins. These complexes are essential for the proper development and specialization of blood vessels, helping to distinguish between arteries and veins. Because of its involvement in vascular integrity, mutations in the ENG gene are well-documented in medical literature, particularly in relation to hereditary hemorrhagic telangiectasia type 1 (HHT1), a condition characterized by abnormal blood vessel formation. While severe mutations in this gene can have significant health impacts, the vast majority of genetic variants, including many SNPs found in the non-coding or regulatory regions of the gene, do not necessarily disrupt the production or function of the endoglin protein.
Research and Evidence
The evidence regarding rs1060501419 is currently categorized as moderate in terms of its presence in genomic catalogs. It has been identified in various genomic studies, but it is not widely cited as a primary driver of specific clinical conditions in the current peer-reviewed literature. In genomics, a variant's evidence strength often depends on how consistently it appears in association studies and whether functional experiments have confirmed a biological effect. For rs1060501419, the current data is largely descriptive, meaning it has been observed in population-level sequencing but lacks a definitive link to a specific, well-characterized trait or disease outcome. As with many variants in the ENG gene region, researchers continue to investigate whether such markers might influence gene expression or protein levels under specific environmental or physiological conditions. Readers should be aware that genomic science is an evolving field, and our understanding of the functional consequences of such variants may change as more data becomes available.
Population Frequency and Interpretation
Information regarding the specific population frequency of rs1060501419 is not currently specified in major public databases. Genetic variants can vary significantly in frequency across different ancestral groups, with some being common in certain populations and rare or absent in others. Without specific frequency data, it is difficult to determine how widespread this variant is globally. When interpreting genetic information, it is essential to remember that a single variant rarely acts in isolation. Most human traits and health outcomes are polygenic, meaning they are influenced by the combined effects of many different genetic markers, as well as lifestyle and environmental factors. Consequently, the presence of a single SNP like rs1060501419 should not be used to draw conclusions about personal health or disease risk. Genetic data is best understood in the context of a comprehensive clinical evaluation performed by a qualified healthcare professional.
What You Can Do With This Information
If you have encountered this variant in a personal genetic report, it is important to maintain a balanced perspective. Most variants identified in large-scale genomic studies are neutral, meaning they do not have a known impact on health. You cannot use this information to diagnose yourself or predict future health outcomes. If you are concerned about your cardiovascular health or have a family history of conditions related to blood vessel development, the most effective step is to consult with a physician or a genetic counselor. These professionals can help you interpret your overall genetic profile in the context of your medical history and current health status. Avoid making any changes to your lifestyle or medical care based solely on a single SNP result. Always rely on validated clinical testing and professional medical advice rather than raw genomic data, which is intended for research and educational purposes only.
How common is this variant?
Specific population frequency data for rs1060501419 is not currently available in major public genomic databases.
Frequently asked questions
Is rs1060501419 a dangerous mutation?
There is no evidence to suggest that rs1060501419 is a dangerous mutation. It is a common genetic variant, and most such variants have no known impact on health.
Does this variant cause HHT1?
No. Hereditary hemorrhagic telangiectasia type 1 (HHT1) is caused by specific, pathogenic mutations in the ENG gene that disrupt protein function. This SNP is not classified as one of those pathogenic mutations.
Should I be worried about my ENG gene results?
You should not be worried. Most genetic variants are normal variations in human DNA. If you have specific health concerns, please discuss them with your doctor.
Where can I find more information about my specific genotype?
You can search for your rsID on the NCBI dbSNP database or the GWAS Catalog. These resources provide the most up-to-date scientific information on known variants.
Sources & further reading
Educational information only, last refreshed 10/9/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1060501419?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.